TruScreen has provided an update on its key markets, highlighting several significant developments.
The company has received regulatory approval in Uzbekistan, allowing it to commence a validation program as a precursor to a planned major screening program.
In Zimbabwe, the validation process is set to begin on July 7 and be completed by July 21, which will facilitate the recommencement of a major public screening program.
TruScreen's screening program in Ho Chi Minh City, Vietnam, is on track to start on July 28, with staff training already completed and device shipments underway.
Additionally, the company announced its first commercial sales in India, with a purchase order from Renovate Biologicals.
A study conducted in Beijing, China, has confirmed TruScreen's superiority to other screening methods, and the results have been published by Dovepress.
See more
